Derek John Michael Miller - 10 Apr 2023 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
4
Filing time
10 Apr 2023, 20:10:07 UTC
Next filing
08 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 10 Apr 2023 Common Stock 50,000 $9.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in 36 equal monthly installments starting one month after grant date of April 10, 2023.